ACR Convergence 2025| Video: Rheuminations on Milestones & Ageism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: hospital

Eosinophilic Gastroenteritis & Eosinophilic Ascites Associated with RA

Helen Lyo, Eugene Han, MD, Shivakumar Vignesh, MD, & Nancy Soloman, MD  |  June 17, 2019

Eosinophilic gastroenteritis (EGE) is a rare condition caused by eosinophilic infiltration of the gastrointestinal (GI) tract. The condition is subdivided into the GI layers it affects: mucosal, muscular and subserosal.1 EGE usually presents with non-specific GI symptoms, such as impaired motility, intestinal obstruction and, rarely, ascites.2 Below, we report a rare case of EGE leading…

Filed under:ConditionsRheumatoid Arthritis Tagged with:Eosinophilic AscitesEosinophilic Gastroenteritis

Thinking Big, Thinking Small

Philip Seo, MD, MHS  |  June 17, 2019

I would like to tell you a story. Two, actually. I am just returning from the 19th International Vasculitis and ANCA Workshop, which is always a fascinating meeting. In its inception, it was a workshop, in the true sense of the word. Now, we discuss anti-neutrophil cytoplasmic antibody (ANCA) testing as casually as we discuss…

Filed under:ConditionsVasculitis Tagged with:ANCA-Associated Vasculitisanti-neutrophil cytoplasmic antibodies (ANCA)genomicsInternational Vasculitis and ANCA WorkshopKawasaki disease

Cincinart / shutterstock.com

Case Report: Sjögren’s Syndrome Plus Neuromyelitis Optica Spectrum Disorder

Swosti Roka Magar, MD, Gita Verma, MD, & Aaroop Haridas, MD   |  June 17, 2019

Sjögren’s syndrome is a chronic multi-system autoimmune disease characterized by inflammation and subsequent destruction of exocrine glands. Sjögren’s syndrome can present with glandular or extra-glandular manifestations. Neuromyelitis optica spectrum disorder (NMOSD) is a rare central nervous system (CNS) autoimmune disease that can present as the initial manifestation in less than 5% of patients with Sjögren’s….

Filed under:ConditionsOther Rheumatic ConditionsSjögren’s Disease Tagged with:immunosuppressive drugsMultiple Sclerosisneuromyelitis optica spectrum disorder (NMOSD)Sjogren's

Biological DMARDs in Elderly RA Patients: Use, Maintenance & Discontinuation

Natasha Yetman  |  June 17, 2019

A study comparing seven biologic DMARDs in RA patients aged 65 years and older found abatacept had the highest retention rate and the lowest discontinuation rate…

Filed under:ConditionsRheumatoid Arthritis Tagged with:abataceptadalimumabbiologic disease-modifying antirheumatic drugsbiologic DMARDsCertolizumab PegoletanerceptGolimumabinfliximabRheumatoid Arthritis (RA)tocilizumab

Beyond Addiction: Medical Therapy for Addiction May Benefit Medical Adherence

Thomas R. Collins  |  June 17, 2019

Treating patients with rheumatic disease for their addictions will also encourage patients to address their overall health conditions, resulting in better medical adherence…

Filed under:Conditions Tagged with:Addictionaddiction treatmentOpioid abuseOpioids

Risk Assessment & Treatment in APS Patients

Thomas R. Collins  |  June 12, 2019

The pathogenesis of antiphospholipid syndrome (APS) is complicated and may involve local inflammation, vasculopathy, pregnancy complications and thrombosis. During the 2019 ACR State-of-the-Art Clinical Symposium, Lisa Sammaritano, MD, addressed the risk assessment and treatment of APS patients…

Filed under:ConditionsOther Rheumatic Conditions Tagged with:2019 State-of-the-Art Clinical SymposiumAntiphospholipid Antibody Syndrome (APS)Hughes Syndromeriskrisk assessmentthrombosis

Vaccines & Rheumatology Patients

Thomas R. Collins  |  June 12, 2019

Vaccines are often safe for rheumatology patients, but precautions may be needed, said Brian Schwartz, MD, at the 2019 ACR State-of-the-Art Clinical Symposium…

Filed under:Conditions Tagged with:2019 State-of-the-Art Clinical Symposiumpatient carevaccinationvaccines

A Bridge Between Patients & Rheumatologists: What Social Workers Want Rheumatologists to Know

Linda Childers  |  June 4, 2019

An integral part of the rheumatology care team, social workers can address specific issues related to a patient’s overall wellbeing. Here are some insights into how rheumatologists can better partner with social workers as part of the interdisciplinary team to ensure better patient outcomes…

Filed under:Practice Support Tagged with:Association of Rheumatology Professionals (ARP)Care Teamhealthcare teammultidisciplinary care teampatient caresocial worker

Tofacitinib + Methotrexate: 2-Year Clinical, Radiographic & Safety Outcomes

Michele B. Kaufman, PharmD, BCGP  |  June 4, 2019

In a 24-month clinical trial, tofacitinib proved safe and effective in combination with methotrexate in adult patients with RA…

Filed under:Drug Updates Tagged with:MethotrexateRheumatoid Arthritis (RA)Tofacitinib

FDA Approves Risankizumab, Adds Stronger Warning to Sleep Medications

Michele B. Kaufman, PharmD, BCGP  |  May 29, 2019

The FDA has approved rizankixumab to treat adults with plaque psoriasis and added boxed warnings to sleep medications…

Filed under:Biologics/DMARDsDrug Updates Tagged with:FDAplaque psoriasisrizankixumabSleepU.S. Food and Drug Administration (FDA)

  • « Previous Page
  • 1
  • …
  • 128
  • 129
  • 130
  • 131
  • 132
  • …
  • 330
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences